InsightRX
InsightRX, a pharmacology software platform, uses machine learning to optimize patient treatment and dosing decisions.
Founded
2015InsightRX, a pharmacology software platform, uses machine learning to optimize patient treatment and dosing decisions.
InsightRX, founded with a mission to revolutionize personalized medicine, leverages quantitative pharmacology and machine learning to optimize patient treatment and dosing decisions. The company offers a suite of clinical decision support tools designed to provide real-time, individualized treatment insights at the point-of-care. Their platform supports healthcare providers and biopharma companies by delivering precision dosing, real-time clinical analytics, and model-informed precision dosing across various therapeutic areas, including infectious diseases and bone marrow transplants.
Notable figures affiliated with InsightRX include leading experts in pharmacology and data science. The company has secured investments from prominent venture capital firms specializing in healthcare technology. Key achievements include the successful integration of their platform in numerous clinical settings, demonstrating improved patient outcomes and treatment efficacy. InsightRX's impact is evident in its ability to enhance personalized medicine, making significant strides in the field of precision dosing and individualized patient care.
Companies similar to InsightRX include DecisionRx, RxAnte, ProspectRx and RxVantage.
InsightRX was founded in 2015.
InsightRX's headquarters is located in San Francisco, CA, US.
InsightRX's most recent funding round was for $10M (USD) in September 2019.
As of Sep 19, 2019, InsightRX has disclosed funding of $12.8M (USD). Undisclosed round amounts are excluded.
InsightRX has 30 employees as of Feb 5, 2024.
rxvantage.com
